Publications by authors named "Vincent Rajkumar"

Claim this Profile
R
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysis.
Saurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, Matthew Thorpe, Cem Bilgin, S Vincent Rajkumar

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining IgM Multiple Myeloma.
Mahin Bhatt, Anaelle Zimmowitch, Hadiyah Yasin Audil, S Vincent Rajkumar

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Characteristics, Treatment Responses and Outcomes of Light Chain Multiple Myeloma.
Abiola Bolarinwa, Saurabh Zanwar, Nadine Abdallah, Francis K Buadi, Suzanne R Hayman, S Vincent Rajkumar

Am J Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma.
Meletios A Dimopoulos, Sagar Lonial, Wee-Joo Chng, Shinsuke Iida, María-Victoria Mateos, S Vincent Rajkumar

Blood Cancer J· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Measurable residual disease assessment in multiple myeloma.
Saurabh Zanwar, S Vincent Rajkumar

Leukemia· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current risk stratification and staging of multiple myeloma and related clonal plasma cell disorders.
Saurabh Zanwar, S Vincent Rajkumar

Leukemia· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Cell Disorders and Mayo Clinic Proceedings.
S Vincent Rajkumar

Mayo Clin Proc· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining the proteome of bone marrow plasma in multiple myeloma and monoclonal gammopathy of undetermined significance.
Joel-Sean Hsu, Udit Yadav, Kishore Garapati, Kiran K Mangalaparthi, Yogesh Chawla, S Vincent Rajkumar

Blood Cancer J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Whole-Exome Sequencing-Based Linkage Analysis of Multiple Myeloma (MM) and Monoclonal Gammopathy of Undetermined Significance (MGUS) Pedigrees.
Alyssa I Clay-Gilmour, Nicola J Camp, Xiaomu Wei, Angel Earle, Aaron Norman, Vincent Rajkumar

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Gammopathy of Undetermined Significance.
S Vincent Rajkumar, Shaji Kumar

N Engl J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.
Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu, Shaji Kumar, Kylee Maclachlan, S Vincent Rajkumar

J Clin Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AL Amyloidosis: A Real-World Experience with CAR-T Cell Therapy.
Melinda Sy Tan, Rahma Warsame, Ricardo D Parrondo, Eli Muchtar, Taxiarchis V Kourelis, S Vincent Rajkumar

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma.
Matthew J Rees, Timothy T Xu, Suheil Albert Atallah-Yunes, Kenneth J C Lim, Sikander Ailawadhi, S Vincent Rajkumar

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic involvement in light chain amyloidosis: analysis of 130 patients and predictors of hepatic response and survival.
Matthew J Rees, Nadia Toumeh, Angela Dispenzieri, Morie Gertz, Binoy Yohannan, S Vincent Rajkumar

Amyloid· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal Gammopathies in Africa.
Abiola Bolarinwa, Lateef Odukoya, Francis Buadi, Vincent Rajkumar, Shaji Kumar

Clin Lymphoma Myeloma Leuk· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 is a highly prognostic biomarker for POEMS syndrome.
Joselle Cook, Rahma Warsame, Maryam Omar, Francis K Buadi, Nadine Abdallah, S Vincent Rajkumar

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solitary but not simple─a call for precision risk stratification and individualized treatment in solitary plasmacytoma.
Saurabh Zanwar, S Vincent Rajkumar

Leukemia· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal genomic dynamics shape clinical trajectory in multiple myeloma.
Francesco Maura, Marcella Kaddoura, Alexandra M Poos, Linda B Baughn, Bachisio Ziccheddu, S Vincent Rajkumar

Nat Genet· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of residual clonal plasma cells in S-phase at the time of autologous stem cell transplantation on clinical outcomes.
Tamer Hellou, Daniel G Packard, Suheil Albert Atallah-Yunes, Ahauve M Orusa, Shinichiro Suzuki, S Vincent Rajkumar

Blood Cancer J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, Jill Corre, Mattia D'Agostino, S Vincent Rajkumar

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: International Myeloma Society/International Myeloma Working Group Consensus Recommendations on the Definition of High-Risk Multiple Myeloma.
Hervé Avet-Loiseau, Faith E Davies, Mehmet K Samur, Jill Corre, Mattia D'Agostino, S Vincent Rajkumar

J Clin Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis.
Eli Muchtar, Angela Dispenzieri, Francis K Buadi, Prashant Kapoor, David Dingli, S Vincent Rajkumar

Blood Adv· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab for High-Risk Smoldering Multiple Myeloma. Reply.
Meletios A Dimopoulos, Peter M Voorhees, S Vincent Rajkumar

N Engl J Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresis.
Elham Askari, Angela Dispenzieri, Francis K Buadi, Suzanne R Hayman, Morie A Gertz, S Vincent Rajkumar

Blood Cancer J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imaging in plasma cell disorders-consensus recommendations of the Asian myeloma network bone imaging workgroup.
Chandramouli Nagarajan, Natasha Fay Anthony, Jens Hillengass, Seok Jin Kim, Chutima Kunacheewa, S Vincent Rajkumar

Lancet Reg Health West Pac· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis